FR1425700A - Composés formant des complexes métalliques et procédé pour les préparer et les utiliser - Google Patents

Composés formant des complexes métalliques et procédé pour les préparer et les utiliser

Info

Publication number
FR1425700A
FR1425700A FR6472A FR6472A FR1425700A FR 1425700 A FR1425700 A FR 1425700A FR 6472 A FR6472 A FR 6472A FR 6472 A FR6472 A FR 6472A FR 1425700 A FR1425700 A FR 1425700A
Authority
FR
France
Prior art keywords
preparing
metal complexes
forming metal
compounds forming
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR6472A
Other languages
English (en)
Inventor
Paul Lagally
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF SE
Original Assignee
BASF SE
Badische Anilin and Sodafabrik AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BASF SE, Badische Anilin and Sodafabrik AG filed Critical BASF SE
Priority to FR6472A priority Critical patent/FR1425700A/fr
Application granted granted Critical
Publication of FR1425700A publication Critical patent/FR1425700A/fr
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/02Polyamines
    • C08G73/0233Polyamines derived from (poly)oxazolines, (poly)oxazines or having pendant acyl groups
FR6472A 1965-02-22 1965-02-22 Composés formant des complexes métalliques et procédé pour les préparer et les utiliser Expired FR1425700A (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR6472A FR1425700A (fr) 1965-02-22 1965-02-22 Composés formant des complexes métalliques et procédé pour les préparer et les utiliser

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR6472A FR1425700A (fr) 1965-02-22 1965-02-22 Composés formant des complexes métalliques et procédé pour les préparer et les utiliser

Publications (1)

Publication Number Publication Date
FR1425700A true FR1425700A (fr) 1966-01-24

Family

ID=1576066

Family Applications (1)

Application Number Title Priority Date Filing Date
FR6472A Expired FR1425700A (fr) 1965-02-22 1965-02-22 Composés formant des complexes métalliques et procédé pour les préparer et les utiliser

Country Status (1)

Country Link
FR (1) FR1425700A (fr)

Cited By (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10669271B2 (en) 2018-03-30 2020-06-02 Incyte Corporation Heterocyclic compounds as immunomodulators
US10793565B2 (en) 2016-12-22 2020-10-06 Incyte Corporation Heterocyclic compounds as immunomodulators
US10800768B2 (en) 2016-12-22 2020-10-13 Incyte Corporation Heterocyclic compounds as immunomodulators
US10806785B2 (en) 2016-12-22 2020-10-20 Incyte Corporation Immunomodulator compounds and methods of use
US10906920B2 (en) 2018-05-11 2021-02-02 Incyte Corporation Heterocyclic compounds as immunomodulators
US11401279B2 (en) 2019-09-30 2022-08-02 Incyte Corporation Pyrido[3,2-d]pyrimidine compounds as immunomodulators
US11407749B2 (en) 2015-10-19 2022-08-09 Incyte Corporation Heterocyclic compounds as immunomodulators
US11465981B2 (en) 2016-12-22 2022-10-11 Incyte Corporation Heterocyclic compounds as immunomodulators
US11535615B2 (en) 2015-12-22 2022-12-27 Incyte Corporation Heterocyclic compounds as immunomodulators
US11572366B2 (en) 2015-11-19 2023-02-07 Incyte Corporation Heterocyclic compounds as immunomodulators
US11608337B2 (en) 2016-05-06 2023-03-21 Incyte Corporation Heterocyclic compounds as immunomodulators
US11613536B2 (en) 2016-08-29 2023-03-28 Incyte Corporation Heterocyclic compounds as immunomodulators
US11673883B2 (en) 2016-05-26 2023-06-13 Incyte Corporation Heterocyclic compounds as immunomodulators
US11718605B2 (en) 2016-07-14 2023-08-08 Incyte Corporation Heterocyclic compounds as immunomodulators
US11753406B2 (en) 2019-08-09 2023-09-12 Incyte Corporation Salts of a PD-1/PD-L1 inhibitor
US11760756B2 (en) 2020-11-06 2023-09-19 Incyte Corporation Crystalline form of a PD-1/PD-L1 inhibitor
US11780836B2 (en) 2020-11-06 2023-10-10 Incyte Corporation Process of preparing a PD-1/PD-L1 inhibitor
US11866451B2 (en) 2019-11-11 2024-01-09 Incyte Corporation Salts and crystalline forms of a PD-1/PD-L1 inhibitor
US11866434B2 (en) 2020-11-06 2024-01-09 Incyte Corporation Process for making a PD-1/PD-L1 inhibitor and salts and crystalline forms thereof
US11873309B2 (en) 2016-06-20 2024-01-16 Incyte Corporation Heterocyclic compounds as immunomodulators

Cited By (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11407749B2 (en) 2015-10-19 2022-08-09 Incyte Corporation Heterocyclic compounds as immunomodulators
US11572366B2 (en) 2015-11-19 2023-02-07 Incyte Corporation Heterocyclic compounds as immunomodulators
US11535615B2 (en) 2015-12-22 2022-12-27 Incyte Corporation Heterocyclic compounds as immunomodulators
US11866435B2 (en) 2015-12-22 2024-01-09 Incyte Corporation Heterocyclic compounds as immunomodulators
US11608337B2 (en) 2016-05-06 2023-03-21 Incyte Corporation Heterocyclic compounds as immunomodulators
US11673883B2 (en) 2016-05-26 2023-06-13 Incyte Corporation Heterocyclic compounds as immunomodulators
US11873309B2 (en) 2016-06-20 2024-01-16 Incyte Corporation Heterocyclic compounds as immunomodulators
US11718605B2 (en) 2016-07-14 2023-08-08 Incyte Corporation Heterocyclic compounds as immunomodulators
US11613536B2 (en) 2016-08-29 2023-03-28 Incyte Corporation Heterocyclic compounds as immunomodulators
US11566026B2 (en) 2016-12-22 2023-01-31 Incyte Corporation Heterocyclic compounds as immunomodulators
US11787793B2 (en) 2016-12-22 2023-10-17 Incyte Corporation Heterocyclic compounds as immunomodulators
US10793565B2 (en) 2016-12-22 2020-10-06 Incyte Corporation Heterocyclic compounds as immunomodulators
US11339149B2 (en) 2016-12-22 2022-05-24 Incyte Corporation Heterocyclic compounds as immunomodulators
US10806785B2 (en) 2016-12-22 2020-10-20 Incyte Corporation Immunomodulator compounds and methods of use
US11465981B2 (en) 2016-12-22 2022-10-11 Incyte Corporation Heterocyclic compounds as immunomodulators
US10800768B2 (en) 2016-12-22 2020-10-13 Incyte Corporation Heterocyclic compounds as immunomodulators
US10669271B2 (en) 2018-03-30 2020-06-02 Incyte Corporation Heterocyclic compounds as immunomodulators
US11124511B2 (en) 2018-03-30 2021-09-21 Incyte Corporation Heterocyclic compounds as immunomodulators
US11414433B2 (en) 2018-05-11 2022-08-16 Incyte Corporation Heterocyclic compounds as immunomodulators
US10906920B2 (en) 2018-05-11 2021-02-02 Incyte Corporation Heterocyclic compounds as immunomodulators
US11753406B2 (en) 2019-08-09 2023-09-12 Incyte Corporation Salts of a PD-1/PD-L1 inhibitor
US11401279B2 (en) 2019-09-30 2022-08-02 Incyte Corporation Pyrido[3,2-d]pyrimidine compounds as immunomodulators
US11866451B2 (en) 2019-11-11 2024-01-09 Incyte Corporation Salts and crystalline forms of a PD-1/PD-L1 inhibitor
US11780836B2 (en) 2020-11-06 2023-10-10 Incyte Corporation Process of preparing a PD-1/PD-L1 inhibitor
US11866434B2 (en) 2020-11-06 2024-01-09 Incyte Corporation Process for making a PD-1/PD-L1 inhibitor and salts and crystalline forms thereof
US11760756B2 (en) 2020-11-06 2023-09-19 Incyte Corporation Crystalline form of a PD-1/PD-L1 inhibitor

Similar Documents

Publication Publication Date Title
FR1425700A (fr) Composés formant des complexes métalliques et procédé pour les préparer et les utiliser
BE780486A (fr) Procédé et composition pour enduire les métaux
FR1437829A (fr) Procédé de formation de revêtements métalliques
FR1517737A (fr) Procédé pour réduire l'intensité des rayonnements électromagnétiques indésirables
FR1505430A (fr) 11-désoxyprostaglandines et procédé pour les préparer
FR1482547A (fr) Procédé pour fabriquer des nouvelles 2-amino-halogéno-benzylamines
FR1481053A (fr) Nouveau procédé pour la préparation des imino-thiazolines
FR1499032A (fr) Procédé pour la réduction de silanes substitués
FR1503133A (fr) Procédé perfectionné de revêtement de métaux
FR1498843A (fr) Supraconducteur et procédé pour le former
FR1469198A (fr) Nouveau procédé d'enrobage des explosifs
FR1493772A (fr) Procédé pour le traitement des érythrocytes
FR1470297A (fr) électrodes et procédé pour les produire
FR1539158A (fr) Procédé pour régulariser et ralentir la prise des liants hydrauliques
FR1449543A (fr) Composition et procédé pour former des revêtements améliorés sur des métaux
FR95359E (fr) Procédé pour régulariser et ralentir la prise des liants hydrauliques.
FR1472897A (fr) Procédé d'hydrocraquage pour améliorer les naphtas
FR1418488A (fr) Sujets décoratifs et procédé pour les fabriquer
CH460250A (fr) Procédé pour traiter les cheveux
FR1495678A (fr) Tuyau et procédé pour le fabriquer
FR1436544A (fr) Procédé pour le placage des métaux
FR1513180A (fr) Complexes de composés du benzothiazolium et procédé pour les préparer
FR1492726A (fr) Procédé pour la production de diènes
FR1433954A (fr) Procédé pour l'application de revêtements
FR1394830A (fr) Appareil et procédé de formage électromagnétique d'une pièce